Results 191 to 200 of about 555,062 (342)

Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.

open access: green, 1988
Margaret A. Shipp   +7 more
openalex   +1 more source

Imatinib decreases germ cell survival and germline stem cell proliferation in rodent testis ex vivo and in vitro

open access: yesAndrology, EarlyView.
Abstract Background Imatinib and dasatinib are tyrosine kinase inhibitors (TKIs) increasingly used to treat several diseases in both children and adults at fertile age. We have previously shown that imatinib has adverse effects on developing testis, and imatinib‐treated male patients have been reported to have reduced sperm counts.
Anna Eggert   +10 more
wiley   +1 more source

Efficacy of NAMPT inhibition in T-cell acute lymphoblastic leukemia. [PDF]

open access: yesPLoS One
Vrana C   +10 more
europepmc   +1 more source

Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia [PDF]

open access: bronze, 1983
FS Muriel   +11 more
openalex   +1 more source

Clinical Utility and Cost‐Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine‐Induced Myelosuppression: A Genotype‐First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Carriage of any loss of function NUDT15 varaint is associated with an increased risk of thiopurine‐induced myelosuppression. Pre‐treatment genotype testing of NUDT15. ABSTRACT Background The clinical utility and cost‐effectiveness of pre‐thiopurine NUDT15 pharmacogenetic testing in European and admixed populations are unknown.
Christopher Roberts   +34 more
wiley   +1 more source

Wernicke Encephalopathy in a Child With Acute Lymphoblastic Leukemia: A Case Report. [PDF]

open access: yesCancer Rep (Hoboken)
Shakibamaram G   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy